Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to the late-breaking ASCEND study presented at the American Heart Association’s Scientific Sessions 2021. Type 2 Diabetes and Aspirin Regimen. #AHA
News | Antiplatelet and Anticoagulation Therapies
Long-term, Low-dose Aspirin Did Not Affect Risk of Dementia in Adults With Type 2 Diabetes

November 17, 2021 — Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline ...

Home November 17, 2021
Home
News | Atrial Fibrillation
Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

Home November 17, 2021
Home
Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and quality of life within 3 months for people with heart failure due to either reduced or preserved cardiac function, even if they didn’t also have type 2 diabetes, according to the late-breaking CHIEF-HF study presented at the American Heart Association’s Scientific Sessions 2021. Type 2 Diabetes Canagliflozin 100mg Tablet.
News | Heart Failure
Heart Failure Symptoms Improved With a Type 2 Diabetes Medicine in Fully Remote Trial

November 17, 2021 — Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and ...

Home November 17, 2021
Home
People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with higher rates of poverty, crowded living situations and/or a higher proportion of people from diverse racial and ethnic groups, had higher rates of death and cardiac events such as a heart attack or stroke when hospitalized with COVID-19, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2021. #AHA21 #AHA
News | Coronavirus (COVID-19)
People Hospitalized With COVID-19 From Poor Neighborhoods Had Higher Rate of Heart Events

November 17, 2021 — People in the U.S. who live in socially vulnerable neighborhoods, which includes communities with ...

Home November 17, 2021
Home
For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief, early aortic valve replacement surgery may be beneficial because it reduces the risk of death, heart attack, stroke and heart failure, according to the late-breaking AVATAR trial presented at the American Heart Association’s Scientific Sessions 2021.  #AHA #AHA21
News | Structural Heart
Surgery to Replace Heart Valve Beneficial Even With No Symptoms of Severe Aortic Stenosis

November 17, 2021 — For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief ...

Home November 17, 2021
Home
News | EP Lab
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy for Atrial Fibrillation

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

Home November 16, 2021
Home
Videos | Cardiogenic Shock
VIDEO: Updates Made to the SCAI Cardiogenic Shock Classifications

Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...

Home November 16, 2021
Home
News | Pharmaceuticals
Bempedoic Acid Alone Lowered LDL-C Levels Comparable to Moderate or High-intensity Statin

November 15, 2021 — Esperion announced the presentation of three abstracts highlighting Nexletol tablets at the American ...

Home November 15, 2021
Home
News | EP Lab
FDA Clears vMap Technology to Identify Arrhythmia Hot Spots Using Only ECG

November 15, 2021 — Vektor Medical Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Home November 15, 2021
Home
RealView Imaging Holoscope-i Medical Holographic Imaging System
Feature | Cath Lab
RealView Imaging Receives FDA for Holoscope-i Medical Holographic Imaging System

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
News | Pharmaceuticals
Inclisiran Reduced LDL-C in Obese Patients

November 15, 2021 — Novartis announced results from a pooled post-hoc analysis of Phase III ORION-9, -10 and -11 trials ...

Home November 15, 2021
Home
Penumbra Indigo System CAT RX Thrombectomy system was involved in the CHEETAH Trial, study at TCT 2021.#TNT
News | Thrombectomy Devices
New Data Demonstrate Safety and Performance of Continuous Aspiration Thrombectomy With Penumbra’s Indigo System CAT RX Catheter

November 12, 2021 — Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CAT RX Catheter ...

Home November 12, 2021
Home
News | Hypertension
Pacemaker for Hypertension Shows Significant Clinical Impact

November 12, 2021 — Orchestra BioMed Inc. announced multiple presentations of long-term clinical results and ISH ...

Home November 12, 2021
Home
President Joe Biden today announced his intention to nominate cardiologist Robert Califf, M.D., MACC, for the position of commissioner of food and drugs to lead the U.S. Food and Drug Administration (FDA). 
Feature | Cardiovascular Business | By Dave Fornell, DAIC Editor
President Biden Nominates Cardiologist Robert Califf for FDA Commissioner

November 12, 2021 — President Joe Biden today announced his intention to nominate cardiologist Robert Califf, M.D., MACC ...

Home November 12, 2021
Home
Medtronic Apollo Intrepid TMVR is currently in the middle of a U.S. clinical trial. #TCT #TCT21 #TMVR
News | Structural Heart
Medtronic Intrepid Transcatheter Mitral Valve Successfully Uses Transfemoral Delivery

November 10, 2021 — Medtronic presented early data for its self-expanding Intrepid transcatheter mitral valve ...

Home November 10, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now